Ireland· IE-PA-EU/1/18/1334/001
Vaborem 1 g/1 g powder for concentrate for solution for infusion
A meropenem and vaborbactam product containing vaborbactam + meropenem + meropenem trihydrate, registered in Ireland by Menarini International Operations Luxembourg S.A.. The same ATC class is registered in 13 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Meropenem and vaborbactam is registered in 13 of 19 countries.
Countries holding a registration under ATC J01DH52 (meropenem and vaborbactam), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 9 of them publish a price we can compare per daily dose
Meropenem and vaborbactam · ATC J01DH52
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- VABORBACTAM + Meropenem + Meropenem Trihydrate
- Manufacturer
- Menarini International Operations Luxembourg S.A.
- Country
- Ireland (IE)
- ATC code
- J01DH52
- ATC class
- Meropenem and vaborbactam
- Defined daily dose
- 3 g, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/18/1334/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Meropenem and vaborbactam in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandVaborem 1g/1g, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungA. Menarini GmbH
- CzechiaVABOREMMenarini International Operations Luxembourg S.A., Luxembourg
- SpainVABOREM 1 G/1 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONMenarini International Operations Luxembourg S.A.
- FinlandVaboremMenarini International Operations Luxembourg S.A.
- FranceVABOREM 1 g/1 g, poudre pour solution à diluer pour perfusionMENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
- United KingdomVaborem 1g/1g powder for concentrate for solution for infusion vialsA. Menarini Farmaceutica Internazionale SRL
- IcelandVaboremMenarini International Operations Luxembourg S.A.
- NetherlandsVaborem 1 g/1 g, poeder voor concentraat voor oplossing voor infusieMenarini International Operations Luxembourg S.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vaborem
- Liechtenstein · Vaborem
- Norway · Vaborem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8221674d-0099-4c2f-aaa3-d2d48f6b837f GET /v1/drugs/8221674d-0099-4c2f-aaa3-d2d48f6b837f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for concentrate for solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"J01DH52"
],
"strength": null,
"pa_number": "EU/1/18/1334/001",
"substances": [
"VABORBACTAM",
"Meropenem",
"Meropenem Trihydrate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "20/11/2018",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about meropenem and vaborbactam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.